跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 39,054 条关于
“Anavex Life Sciences Corp”
全部
39,054
临床试验
24,281
药物
1,479
机构
1,050
资讯
12,244
去年
Anavex Life Sciences Announces EMA Acceptance of Blarcamesine MAA for Alzheimer's Treatment
去年
Anavex Life Sciences Reports Financial Results and Clinical Advancements in Neurodegenerative Disease Research
去年
Anavex's Blarcamesine Phase IIb/III Alzheimer's Trial Data Accepted for Publication
去年
Anavex Completes Enrollment in Phase 2 Trial of ANAVEX®3-71 for Schizophrenia Treatment
3年前
Anavex's Phase 2b/3 Trial of Blarcamesine Shows Promising Results in Alzheimer's Disease Treatment
去年
Anavex Life Sciences Awaits Topline Results from Rett Syndrome Trial
去年
Anavex's ANAVEX3-71 Shows Promise in Schizophrenia Phase 2 Trial with EEG Biomarker Improvements
去年
Anavex's Blarcamesine Shows Efficacy in Phase IIb/III Alzheimer's Trial
10个月前
Anavex Life Sciences Shares Plummet 50% Following EMA Rejection of Alzheimer's Drug Blarcamesine
去年
Anavex's Blarcamesine MAA Accepted by EMA for Alzheimer's Treatment
第 1 页,共 1225 页
上一页
下一页